Mostrar el registro sencillo del ítem

dc.contributor.authorGómez Pavón, Javier
dc.contributor.authorGonzález del Castillo, Juan
dc.contributor.authorMartín Delgado, María Cruz
dc.contributor.authorMartín Sánchez, Francisco Javier
dc.contributor.authorMartínez-Sellés, Manuel
dc.contributor.authorMolero García, José María
dc.contributor.authorMoreno Guillén, Santiago
dc.contributor.authorRodríguez- Artalejo, Fernando
dc.contributor.authorRuiz-Galiana, Julián
dc.contributor.authorCantón, Rafael
dc.contributor.authorDe Lucas Ramos, Pilar
dc.contributor.authorGarcía-Botella, Alejandra
dc.contributor.authorGarcía-Lledó, Alberto
dc.contributor.authorHernández- Sampelayo, Teresa
dc.contributor.authorBouza, Emilio
dc.date.accessioned2023-05-31T12:19:10Z
dc.date.available2023-05-31T12:19:10Z
dc.date.issued2022
dc.identifier.issn0214-3429spa
dc.identifier.urihttps://hdl.handle.net/10641/3389
dc.description.abstractTwo years after the COVID-19 pandemic, many uncertainties persist about the causal agent, the disease and its future. This document contains the reflection of the COVID-19 working group of the Official College of Physicians of Madrid (ICOMEM) in relation to some questions that remain unresolved. The document includes considerations on the origin of the virus, the current indication for diagnostic tests, the value of severity scores in the onset of the disease and the added risk posed by hypertension or dementia. We also discuss the possibility of deducing viral behavior from the examination of the structure of the complete viral genome, the future of some drug associations and the current role of therapeutic resources such as corticosteroids or extracorporeal oxygenation (ECMO). We review the scarce existing information on the reality of COVID 19 in Africa, the uncertainties about the future of the pandemic and the status of vaccines, and the data and uncertainties about the long-term pulmonary sequelae of those who suffered severe pneumonia.spa
dc.language.isoengspa
dc.publisherRevista Española de Quimioterapiaspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectCOVID-19spa
dc.subjectSARS-CoV2spa
dc.subjectTreatmentspa
dc.subjectVaccinationspa
dc.subjectVirus originspa
dc.subjectDiagnostic scoresspa
dc.subjectDiagnostic testsspa
dc.subjectArterial hypertensionspa
dc.subjectDementiaspa
dc.subjectViral genomespa
dc.titleCOVID-19: Some unresolved issuesspa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent462 KBspa
dc.identifier.doi10.37201/req/028.2022spa
dc.relation.publisherversionhttps://seq.es/abstract/rev-esp-quimioter-2022-april-21-3/spa


Ficheros en el ítem

FicherosTamañoFormatoVer
gomez21apr2022.pdf461.9KbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España